Publication:
Evaluation of hexagonal boron nitride as a new tablet lubricant

dc.contributor.authorsTurkoglu, M; Sahin, I; San, T
dc.date.accessioned2022-03-12T17:18:24Z
dc.date.accessioned2026-01-11T19:08:14Z
dc.date.available2022-03-12T17:18:24Z
dc.date.issued2005
dc.description.abstractIn this study, hexagonal boron nitride (HBN) was evaluated as a new lubricant for pharmaceutical tablet manufacturing. The other conventional lubricants such as magnesium stearate (MGST), stearic acid ( STAC), and glyceryl behenate ( COMP) were also tested along with HBN. Tablets were manufactured on an instrumented single-station tablet press to monitor and quantify the lower punch ejection force (LPEF). The force ratio, tablet crushing strength, disintegration time, and thickness were measured. The lubricant film formation and lubricant distribution in tablets were studied using the scanning electron microscopy (SEM) and electron probe micro analyzer (EPMA). Based on the force ratio, a good lubrication was obtained at 1% for MGST and HBN; in contrast, STAC and COMP did not show a good lubrication. After 1%, all lubricants performed well. MGST was found to be the most effective lubricant based on LPEF - lubricant concentration profile. HBN provided a 50% decrease in LPEF at 2% lubricant concentration and was rated as an effective tablet lubricant. HBN was better than either STAC or COMP. Unlike MGST, HBN had no significant prolongation effect on tablet disintegration times.
dc.identifier.doi10.1081/PDT-200065684
dc.identifier.issn1083-7450
dc.identifier.pubmed16176018
dc.identifier.urihttps://hdl.handle.net/11424/227957
dc.identifier.wosWOS:000231977100005
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS INC
dc.relation.ispartofPHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectlubricants
dc.subjecthexagonal boron nitride
dc.subjecttablets
dc.subjectlower punch ejection force (LPEF)
dc.subjectforce ratio
dc.titleEvaluation of hexagonal boron nitride as a new tablet lubricant
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage388
oaire.citation.issue3
oaire.citation.startPage381
oaire.citation.titlePHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
oaire.citation.volume10

Files